TY - JOUR
T1 - Simultaneous Multiparametric Estimation of AVM Hemodynamics Using MR Fingerprinting Arterial Spin-Labeling
AU - Hu, Zhiyi
AU - Jiang, Dengrong
AU - Shi, Wen
AU - Salim, Hamza A.
AU - Lakhani, Dhairya A.
AU - Xu, Risheng
AU - Huang, Judy
AU - Nael, Kambiz
AU - Lu, Hanzhang
AU - Yedavalli, Vivek S.
N1 - Publisher Copyright:
© 2025 American Society of Neuroradiology. All rights reserved.
PY - 2025/10/1
Y1 - 2025/10/1
N2 - BACKGROUND AND PURPOSE: Accurate hemodynamic characterization of cerebral AVMs is critical for treatment-planning, risk-stratification, and posttreatment monitoring but remains challenging due to their abnormal angioarchitecture. MR-fingerprinting (MRF) arterial spin-labeling (ASL) is a novel, noninvasive technique that enables simultaneous quantification of CBF, arterial CBV (aCBV), and bolus-arrival time (BAT) within a single 5-minute scan. This study evaluates the feasibility of MRF-ASL in assessing AVM hemodynamics and compares its sensitivity for AVM detection with CBF measurements obtained using single-delay pseudocontinuous ASL (pCASL). MATERIALS AND METHODS: Patients with DSA-confirmed AVMs were scanned on a 3T MRI system. Imaging protocols included MRF-ASL, standard single-delay pCASL, and T2-weighted MRI. MRF-ASL simultaneously-derived CBF, aCBV, and BAT, with CBF estimated using 2 kinetic models: a 1-compartment model, which reflects combined tissue and arterial contributions, and a 2-compart-ment model, which separates arterial signal from tissue perfusion. Regions of interest were manually drawn over the AVM nidus and contralateral nonaffected tissue. MRF-ASL parameters and pCASL-derived CBF were compared between the AVM nidus and nonaffected tissue. Additionally, linear regression analyses were conducted to examine the relationships among MRF-ASL parameters, single-delay pCASL CBF, and the Spetzler-Martin (SM) grade. RESULTS: Six patients with AVMs with SM grades ranging from 1 to 5 were included in this study. MRF-ASL parameters revealed significantly elevated CBF1-compartment (AVM, 129.3 [SD, 21.5 mL/100 g/minute] versus nonaffected, 51.6 [SD, 23.9 mL/100 g/minute], P ¼ .03), CBF2-compartment (AVM, 109.8 [SD, 24.4 mL/100 g/minute] versus nonaffected, 36.6 [SD, 18.6 mL/100 g/minute], P ¼ .03), aCBV (AVM, 7.0 [SD, 4.5%] versus nonaffected, 0.6 [SD, 0.4%], P ¼ .03), and shortened BAT (AVM, 784 [SD, 337 ms] versus nonaffected, 1099 [SD, 500 ms], P ¼ .03) in the AVM nidus compared with contralateral nonaffected tissue in the same patient. In contrast, no significant difference was observed for pCASL CBF (AVM, 47.5 [SD, 49.2 mL/100 g/minute] versus nonaffected, 39.4 [SD, 14.0 mL/100 g/minute], P ¼ .44). A significant positive correlation was identified between the SM grade and both CBF2-compartment (P ¼ .006) and aCBV (P ¼ .005). No association was found for CBF1-compartment (P ¼ .12), BAT (P ¼ .15), or pCASL CBF (P ¼ .13). CONCLUSIONS: In our preliminary study, MRF-ASL has the potential to provide comprehensive and multiparametric evaluation of AVM hemodynamics, demonstrating superior sensitivity for detecting AVM abnormalities compared with single-delay pCASL. These findings show the feasibility of MRF-ASL as a potentially useful tool for noninvasive characterization and monitoring of AVMs.
AB - BACKGROUND AND PURPOSE: Accurate hemodynamic characterization of cerebral AVMs is critical for treatment-planning, risk-stratification, and posttreatment monitoring but remains challenging due to their abnormal angioarchitecture. MR-fingerprinting (MRF) arterial spin-labeling (ASL) is a novel, noninvasive technique that enables simultaneous quantification of CBF, arterial CBV (aCBV), and bolus-arrival time (BAT) within a single 5-minute scan. This study evaluates the feasibility of MRF-ASL in assessing AVM hemodynamics and compares its sensitivity for AVM detection with CBF measurements obtained using single-delay pseudocontinuous ASL (pCASL). MATERIALS AND METHODS: Patients with DSA-confirmed AVMs were scanned on a 3T MRI system. Imaging protocols included MRF-ASL, standard single-delay pCASL, and T2-weighted MRI. MRF-ASL simultaneously-derived CBF, aCBV, and BAT, with CBF estimated using 2 kinetic models: a 1-compartment model, which reflects combined tissue and arterial contributions, and a 2-compart-ment model, which separates arterial signal from tissue perfusion. Regions of interest were manually drawn over the AVM nidus and contralateral nonaffected tissue. MRF-ASL parameters and pCASL-derived CBF were compared between the AVM nidus and nonaffected tissue. Additionally, linear regression analyses were conducted to examine the relationships among MRF-ASL parameters, single-delay pCASL CBF, and the Spetzler-Martin (SM) grade. RESULTS: Six patients with AVMs with SM grades ranging from 1 to 5 were included in this study. MRF-ASL parameters revealed significantly elevated CBF1-compartment (AVM, 129.3 [SD, 21.5 mL/100 g/minute] versus nonaffected, 51.6 [SD, 23.9 mL/100 g/minute], P ¼ .03), CBF2-compartment (AVM, 109.8 [SD, 24.4 mL/100 g/minute] versus nonaffected, 36.6 [SD, 18.6 mL/100 g/minute], P ¼ .03), aCBV (AVM, 7.0 [SD, 4.5%] versus nonaffected, 0.6 [SD, 0.4%], P ¼ .03), and shortened BAT (AVM, 784 [SD, 337 ms] versus nonaffected, 1099 [SD, 500 ms], P ¼ .03) in the AVM nidus compared with contralateral nonaffected tissue in the same patient. In contrast, no significant difference was observed for pCASL CBF (AVM, 47.5 [SD, 49.2 mL/100 g/minute] versus nonaffected, 39.4 [SD, 14.0 mL/100 g/minute], P ¼ .44). A significant positive correlation was identified between the SM grade and both CBF2-compartment (P ¼ .006) and aCBV (P ¼ .005). No association was found for CBF1-compartment (P ¼ .12), BAT (P ¼ .15), or pCASL CBF (P ¼ .13). CONCLUSIONS: In our preliminary study, MRF-ASL has the potential to provide comprehensive and multiparametric evaluation of AVM hemodynamics, demonstrating superior sensitivity for detecting AVM abnormalities compared with single-delay pCASL. These findings show the feasibility of MRF-ASL as a potentially useful tool for noninvasive characterization and monitoring of AVMs.
UR - https://www.scopus.com/pages/publications/105017999826
U2 - 10.3174/ajnr.A8806
DO - 10.3174/ajnr.A8806
M3 - Article
C2 - 40246547
AN - SCOPUS:105017999826
SN - 0195-6108
VL - 46
SP - 2033
EP - 2040
JO - American Journal of Neuroradiology
JF - American Journal of Neuroradiology
IS - 10
ER -